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HorseEquine Cerebellar Abiotrophy (CA) is a neurological disease found in Arabian horses. CA is characterized by
post-natal degeneration of the Purkinje cells of the cerebellum. Signs of CA include ataxia, head tremors, and a
lack of balance equilibrium. We have discovered a linkage of the CA phenotype to a microsatellite marker on
ECA2 and identiﬁed a region of conserved homozygosity spanning approximately 142 kb. Complete
sequencing of the four genes in this region identiﬁed one SNP found only in Arabian horses, located in
exon 4 of TOE1 and approximately 1200 base pairs upstream of MUTYH, adjacent to a possible binding site for
the transcription factor GATA2. qPCR analysis of cDNA from the cerebella of affected and unaffected horses
suggested that MUTYH expression is down-regulated in affected horses. This SNP may therefore have a
function effect on TOE1, or a regulatory effect onMUTYH by negatively affecting the binding afﬁnity of GATA2.GenBank SNP Library dbSNP.
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Cerebellar Abiotrophy (CA) is a neurological condition, character-
ized by a post-natal degeneration of Purkinje cells, which affects a
number of animal species. Cerebellar cortical degeneration involving
extensive loss of Purkinje cells has been reported in dogs, cattle, cats
and chickens. CA has been identiﬁed in several breeds of dogs,
including Papillons [1], Border Collies [2], English Bulldogs [3],
Brittany Spaniels [4], and Staffordshire Terriers [5]. Both Angus [6]
and Holstein Friesian cattle [7] have been affected by CA. Cats show
variability in the onset of CA; while CA can manifest itself in kittens
before a year of age, published case reports indicate that symptoms of
CA can appear as late as seven years of age [8,9]. In chickens, CA is
known as congenital quiver, although the symptoms and pathological
features are the same as in other species [10]. The etiologies of CA in
these species are unknown and may differ.
Inhorses, CA is foundalmost exclusively in theArabianbreed [11–13].
Symptoms of CA in horses generally appear between six weeks and four
months of age and include intention head tremors, ataxia, exaggerated or
paddling action of the forelegs, awide-based stance and a lack ofmenace
response [12,14,15]. Affected horses may startle easily and fall, and are
often unable to rise from a reclining position. Because the symptoms ofCA are similar to other neurological conditions, correct diagnosis of the
disease can be a challenge and is often reached only after other possible
conditions have been eliminated [13].
Conclusive diagnosis of the disease can only be made post-mortem
by a histopathological exam of the cerebellum. The Purkinje cells are
the most prominently and consistently affected component, but the
degeneration of these cells leads to a concurrent degeneration of the
granular neurons of the cerebellum [11,12,14] and to a disorganiza-
tion of the molecular and granular layers, with remaining Purkinje
cells being small and shrunken [16]. Overall size and thickness of the
cerebellum, however, is largely unaffected [14].
We have previously shown that CA in horses is inherited as a
recessive trait [17]. Therefore, the mating of two carriers will result in
an affected foal in 25% of breedings. While this information is of some
use to Arabian breeders in choosing breeding stock, it is only relevant
if the animals in question are known to have produced affected foals.
Otherwise, the risk of producing an affected foal from a particular
mating is still unknown.
Despite the number of species affected by CA, the genes
responsible for the disease have yet to be identiﬁed. An apoptosis
mechanism has been implicated in the loss of Purkinje cells in CA-
affected horses [13] but no speciﬁc genes, or even genomic regions,
have been identiﬁed. While CA is not fatal, most owners elect to
euthanize affected horses as their lack of coordinationmakes handling
them dangerous for both the horses and handlers. There is thus a
considerable need to identify the genetic mutation responsible for CA,
so that a molecular diagnostic test can be developed to help breeders
avoid producing affected foals.
Table 1
SNPs identiﬁed by gene sequencing and used for CA mapping. Locations of SNPs on
ECA2, surrounding sequence, and type of SNP with associated residues for exonic SNPs
are shown.±
Gene Location dbSNP ss # SNP sequence Type Residues
AKR1A1 12866110 252444779 GAGGCTGGGGCTGC
[G/A]
GCTGGAGGGATC
DMAP 14144436 252444780 GGGACCGAGAATAT
[G/A]
TGTCACCTTGAGC
DMAP 14137370 252444781 CAGGACCTGCAGAA
[G/A]
CTGATAACAGCG
Synonymous Lys→Lys
EIF2B3 13452583 252444782 TGTTGTTATTAAATC
[T/A]
AGAAACAGAACA
FAAH 12120045 252444783 CTGGACTCAGAGGC
[G/A]
CTGCTGGCCCTGC
Synonymous Ala→Ala
IPO13 14370561 252444784 TTCATCCTAGTCAGC
[G/C]
ATCTGATCCAGGG
PIK3R3 12442822 252444785 TTGCACCTCTTTTGA
[A/G]
TTGAATTGCCTGA
PRNPIP 14048685 252444786 TGATTAGAATAACA
[T/G]
TTGCTGTCACATCA
PRNPIP 14112315 252444787 ACTCAGACAGACAC
[A/G]
TATCCATACTGAT
SLC6A9 14333337 252444788 ACCAGGGACAGCAT
[C/T]
ATCATCAGCATCA
Synonymous Ile→ Ile
ZSWIM5 13189648 252444789 CTCTCTGCACCAGCC
[C/G]
TGGGCCGAGACC
ZSWIM5 13417395 252444790 ACACGTATTCACCAT
[C/T]
GCCCGCTACATGG
Synonymous Ile→ Ile
122 L.S. Brault et al. / Genomics 97 (2011) 121–129In this study, we mapped CA to the p-arm of ECA2 by performing a
whole genome scan on four paternal families of Arabian horses
segregating for CA. Further marker development in the identiﬁed
region, as well as homozygosity analysis in affected foals, reﬁned the
CA region to approximately 142 kb. The CA region contains four
annotated genes, including MUTYH and TOE1, both of which are
potential candidate genes. Complete sequencing of the genes in this
region, including introns and intergenic spaces, identiﬁed 22 muta-
tions segregating with CA. One SNP identiﬁed was found to be
exclusive to the Arabian breed and to be completely concordant with
the CA trait, making it an excellent candidate for the CAmutation. This
SNP is located in exon 4 of TOE1 but results in a relatively benign
amino acid substitution [18]. However, it is also located approxi-
mately 1200 base pairs 5− of the start site of MUTYH, which is
transcribed from the opposite strand, and is immediately adjacent to a
possible binding site for the transcription factor GATA2 [19]. The
results of a qPCR analysis on RNA extracted from the cerebella ofTable 2
Allele frequencies for eight microsatellites in the CA region having the highest association
affected with CA. X represents any allele other than that associated with CA.
TKY615 AC(16)2 TG(17)2 TG(15)
274 X 296 X 123 X 206
Random (n=41) .037 .963 .037 .963 .037 .963 .049
Carriers (n=45) .522 .478 .522 .478 .522 .478 .522
Affected (n=24) .958 .042 .958 .042 .958 .042 .979
χ2 (df=1) 105.64 105.64 105.64 106.06
p value pb0.001 pb0.001 pb0.001 pb0.001affected and unaffected horses suggest that MUTYH expression is
reduced in affected horses. The putative CA SNP may therefore have a
regulatory effect onMUTYH by affecting the binding afﬁnity of GATA2.
2. Results
2.1. Mapping of CA
Genome scan analyses using CRIPMAP and data from 335 markers
showed signiﬁcant linkage between CA and microsatellite marker
TKY615 (GenBank: AB103833.1) on ECA2 (RF=0, LOD=5.12).
SIBPAL analysis also supported association of TKY615 to CA
(p=0.01075). There was no evidence of signiﬁcant linkage to any
other genomic regions. To further reﬁne the map position, genotypes
of the CA families were obtained for an additional 25 microsatellites
spanning 6 Mb around TKY615. CA showed signiﬁcant linkage
(LOD≥3.0) to 13 of these additional microsatellites, with 11 of
these having recombination fractions of zero with CA.
Sequencing of genes considered candidates for CA based on
function and/or expression in the cerebellum—DMAP1, PRNPIP,
IPO13, AKR1A1, PIK3R3, SLC6A9, EIF2B3, ZSWIM5 and FAAH—yielded
no causative mutations but led to the discovery of 12 additional SNPs
that were also genotyped on the CA families (Table 1). Eight of these
SNPs showed signiﬁcant linkage (LOD≥3.0) to CA, and all but two had
recombination fractions of zero with CA. Four markers had LOD scores
of 5.12: TG(15), AC(16)2, TG(17)2, and a SNP in PRNPIP (intron 5–6).
SNPs segregating completely with the CA phenotypewere excluded as
being causative by their location within non-coding regions of the
gene or by virtue of being synonymous substitutions.
2.2. Allele frequencies and haplotype construction using markers
associated with CA
Allele frequencies were calculated for eight selected microsatellite
markers in the vicinity of the CA region, including the four
microsatellites showing the highest LOD scores. Allele frequencies
were obtained for the group of affected horses (n=23), known
carriers (n=45) and a control group of Arabian horses drawn from
the general population (n=41). All of the 8 markers tested exhibited
allele frequencies in the affected population that were signiﬁcantly
different (pb .001) from the control population (Table 2).
Haplotypes were constructed for the 83 horses segregating for CA
using all 39 genetic markers across 6 Mb of ECA2. A common
haplotype was identiﬁed in foals affected with CA and known carriers
that spanned approximately 3.36 Mb and that corresponded with
those microsatellites having the highest LOD scores in the linkage
analysis. This further conﬁrmed the linkage analysis results and, with
the additional 51 horses genotyped, reﬁned the location of CA.
Homozygosity was observed for 75% of affected foals in this region.
However, in 87.5% of the affected foals, homozygosity was further
restricted to a 2.24 Mb region, 95.8% of affected foals displayed
homozygosity in a 550 kb region, and 100% of affected foals displayed
homozygosity in a 142 kb region that spanned from intron 3–4 of
TESK2 to a SNP approximately 95 kb distal to HPDL (Table 3). Of the 15with CA (based on LOD scores) in random Arabian horses, known carriers, and horses
TC(32)3i AC(13) TG(15)2 TG(13)
X 401 X 234 X 156 X 245 X
.951 .061 .939 .244 .756 .220 .780 .134 .866
.478 .522 .478 .533 .467 .511 .489 .511 .489
.021 .979 .021 .958 .042 .958 .042 .958 .042
102.57 59 63.2 80.22
pb0.001 pb0.001 pb0.001 pb0.001
Table 3
Regions of conserved homozygosity across 18 genetic markers spanning 3.36 Mb on ECA2 in 23 affected Arabian horses. Regions of homozygosity are shown in blue; regions of heterozygosity are shown in pink.
Horse/marker
Genomic location on ECA2
AT(18)
15264935
AC(38)
14559094
IP013
14364252
481101
14294111
DMAP
14150809
PRNPIP
1403739
TKY615
14067934
AC(16)2
13691925
TG(17)2
13577416
TG(15)
13293497
ZSWIM5
13189648
CA SNP
13074277
TESK2
13047413
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124 L.S. Brault et al. / Genomics 97 (2011) 121–129unaffected horses in the CA sample set and the 41 horses from the
general Arabian population, only three, or 5.3%, were heterozygous for
the extended haplotype spanning the 142 kb region.
2.3. Sequencing of genes in the CA region
The 142 kb region contains four annotated genes in the horse:
TESK2, TOE1, MUTYH, and HPDL. Together, these genes occupy
approximately 46.7 kb of the 142 kb region; the other 95 kb contain
no known genes in the horse. (Fig. 1) Complete sequencing
was performed on the approximately 49.7 kb, from the SNP in intron
3–4 of TESK2 that formed the upper boundary of the region to
approximately 3000 base pairs beyond the 5′-end of HPDL. TheFig. 1. Region of ECA2 identiﬁed as containing the causative CA mutation by haplotype analy
location (by base pair count) is indicated to the right. Relative location of 22 identiﬁed musequencing included exons, introns, and intergenic spaces between all
four genes. At least one affected Arabian horse from the CA families
and one unaffected Arabian horse were sequenced in order to identify
polymorphisms between the samples. Mutations were selected for
further genotyping if they were not present in the unaffected sample
and were homozygous in the affected sample. A total of 22 mutations
were identiﬁed: 19 SNPs, 1 double nucleotide polymorphism (DNP),
one indel, and one insertion (Table 4). Two SNPs were located in
exons, 14 SNPs, the DNP, the insertion and the indel were located in
introns, and one SNP was found in intergenic space.
The 22 polymorphisms were genotyped on the CA families, and
all showed segregation with the CA phenotype. However, when
genotyped on the mixed breed samples, 21 polymorphisms weresis. Boxes indicate annotated genes; arrows indicate direction of transcription. Physical
tations in the region is noted on the left.
Table 4
Twenty-two polymorphisms identiﬁed in a 142 kb region containing the causative mutation for CA. The type of mutation identiﬁed, the nucleic acid change, location (exonic,
intronic, or intergenic), and physical base pair position on ECA2 (EquCab2 draft assembly) are noted. For exonic mutations, the amino acid change (position and amino acid
substitution) are indicated.
Polymorphism Type Base change Source AA change? Location dbSNP ss #
TESK2-34j SNP C –N T Intron 13050853 252444759
TESK2-34u SNP C –N T Intron 13058558 252444760
TESK2-45m SNP T –N C Intron 13059524 252444761
TESK2-45k DNP GC –N TA Intron 13060692 252444762
TESK2-45j SNP T –N C Intron 13061799 252444763
TESK2-45ins Insertion T Intron 13063606 252444791
TESK2-45g SNP T –N C Intron 13063718 252444764
TESK2-45e1 Indel delGAGGinsT Intron 13065301 252444792
TESK2-45e2 SNP A –N G Intron 13065644 252444765
TESK2-45e3 SNP T –N G Intron 13065756 252444766
TESK2-8 SNP G –N A Intron 13069693 252444767
TESK2-9a SNP A –N G Intron 13070359 252444768
TESK2-9b SNP C –N T Intron 13070428 252444769
CA SNP SNP G –N A Exon 95:Arg –N His 13074277 252444770
TOE1-P SNP T –N G Intergenic 13075982 252444771
MUTYH-P14 SNP C –N T Intron 13078958 252444772
MUTYH-P3 SNP T –N G Intron 13085553 252444773
MUTYH-P1 SNP C –N A Intron 13087492 252444774
MUTYH-P2 SNP C –N T Intron 13087753 252444775
MUTYH-6 SNP C –N T Exon 129:Pro –N Leu 13089117 252444776
MUTYH-15a SNP T –N C Intron 13091070 252444777
MUTYH-15b SNP G –N A Intron 13091320 252444778
125L.S. Brault et al. / Genomics 97 (2011) 121–129found in at least three breeds other than Arabians and only one,
identiﬁed as ECA2:13074277, was absent in all samples. (Table S1)
This SNP (G –NA) is located in exon 4 of TOE1, and results in a non-
synonymous substitution of histidine for arginine at this position
(R95H). As arginine and histidine are both small, polar, positively-
charged amino acids [18], it is unclear if this substitution would lead
to a signiﬁcant alteration in protein structure or function. However,
analysis of this amino acid change using the program Polyphen-2 [20]
results in a prediction that this mutation is “probably damaging”
(score: 1.000), due in part to a high degree of evolutionary
conservation at this site. Interestingly, the 5′-end of TOE1 overlaps
with the 5′-end ofMUTYH, leading to transcription of these two genes
from opposite strands of partially overlapping DNA sequences [21].
The sequence preceding the ECA2:13074277 SNP (5′-GAGGATAGAA-
3′) is an 88.1% match for the GATA-2 site (http://molsun1.cbrc.aist.go.
jp/research/db/TFSEARCH.html), thus presenting the alternative
possibility that the SNP could have a regulatory function for MUTYH.
2.4. Quantiﬁcation of MUTYH expression
To investigate the possibility that regulation ofMUTYH expression
is affected by the ECA2:13074277 SNP, we performed a qPCR on cDNA
generated from cerebellar RNA from affected and unaffected (control)
horses. The expression of MUTYH showed considerable variability
between affected and unaffected horses and also between horses of
different ages (Table 5). MUTYH expression increased with the age of
the animal in control and CA-affected horses but affected horses had
comparatively lower levels of expression than the controls. Affected
horses showed a 2.2-fold increase in MUTYH expression between the
5-month-old and the 9-month-old horses, and another 17-fold
increase in expression between the 9-month-old and the 6-year-old
horses. In contrast, the control horses showed 67.25-fold increaseTable 5
Levels of MUTYH and reference gene SYP observed in cDNA samples isolated from the cereb
samples for which qPCR analysis was performed. The ratio of MUTYH expression to SYP exp
Sample Age Quantity mean (MUTYH) Quantity mean (SYP) MUTYH:SYP
CONT-1 2–3 mo. 3.798±2.23 522.629±24.77 0.00727
CONT-1 23.5 mo. 255.423±15.68 1256.958±46.85 0.20321
CONT-3 4 yr. 284.822±20.3 1985.516±37.65 0.14345between the 2-3-month-old and the 23.5-month-old horses and
another 1.16-fold increase between the 23.5-month-old and the 4-
year-old horse.
3. Discussion
Cerebellar abiotrophy is a disease of increasing concern to Arabian
horse owners. Once thought to be a problem of particular families or
speciﬁc lines of breeding, affected CA foals have been identiﬁed that
are of Polish, Egyptian, and Spanish types. While some interbreeding
between these lines is common, analysis of the pedigrees of affected
foals often shows common ancestry more than ﬁve generations
removed. Therefore, it has been unclear whether the CA mutation
arose prior to the geographic segregation and selection of these
various strains, or if perhaps separate CA mutations occurred in
different lineages.
Linkage mapping placed CA on the p-arm of ECA2. Further marker
development and homozygosity analysis in this region has reﬁned the
map location of CA to ECA2: 13,047,413–13,189,648, which spans
approximately 142 kb. We identiﬁed a haplotype in this region that
segregates closely with the CA phenotype. The conservation of this
haplotype among all affected horses strongly suggests that CA arose as
a single mutation prior to the segregation of the Arabian breed into
more closed lineages. This conclusion is further supported by the
speciﬁcity of the CA haplotype; allele frequencies between affected
and control populations are signiﬁcantly different for each of the
alleles associated with CA, and only three of the unaffected horses
(5.3%) that we tested were heterozygous for this haplotype. Given the
number of Arabian lineages producing affected foals, it is entirely
possible that these horses are indeed carriers for CA.
The region of ECA2 identiﬁed in this study has four annotated
genes in the horse: HPDL,MUTYH, TOE1, and TESK2, which span aboutella of three control and three affected horses. Quantities shown are averaged from all
ression is shown.
Sample Age Quantity mean (MUTYH) Quantity mean (SYP) MUTYH:SYP
AFF-1 5 mo. 4.659±1.02 114.485±32.47 0.0407
AFF-2 9 mo. 10.224±3.2 1263.639±13.51 0.00809
AFF-3 6 yr. 173.138±13.74 1860.81±54.24 0.09304
126 L.S. Brault et al. / Genomics 97 (2011) 121–12946.7 kb of the 142 kb region. Complete sequencing of the approxi-
mately 49.7 kb that contain these four genes revealed 22 mutations
that segregated with the CA trait. Of these, only one SNP,
ECA2:13074277, was shown to be present only in the Arabian
breed; all other mutations were found in at least four non-Arabian
breeds, and non-Arabian horses homozygous for each of these
mutations were identiﬁed. As CA has only been identiﬁed in horses
with Arabian ancestry, the occurrence of homozygotes for each of
these SNPs effectively excludes them as candidate mutations for CA.
The ECA2:13074277 SNP is therefore the best and only candidate
mutation identiﬁed in our study.
Two of the four genes in the CA region, MUTYH and TOE1, are
expressed in the brain, although TOE1 is not expressed at high levels
in the cerebellum (BioGPS database, http://biogps.gnf.org/#goto=-
genereport&id=114034). The ECA2:13074277 SNP is located in exon
4 of TOE1, but the amino acid change produced (Arg→His) is not
generally considered to be signiﬁcant [18]. It is therefore unclear if
this SNP affects the functionality of TOE1, although prediction
software suggests that this mutation has a high probability of
negatively affecting functionality of the protein. TOE1, or Target of
EGR1, is a gene target of Early Growth Response 1 (EGR1), which
functions as a transcriptional regulator. TOE1 is a 510-amino acid
protein that mediates the inhibitory growth effect of EGR1, which
directly binds to the promoter region of TOE1 and activates its
expression [22]. TOE1 plays a role in cell cycle regulation by inducing
the expression of TGFβ and p21, and may also modify the activity of
p53 [22,23].
The second possibility is that the ECA2:13074277 SNP affects the
regulation of the MUTYH gene. This SNP lies immediately adjacent to
the 3′-end of a possible GATA-2 binding site. MUTYH, or MutY
Homolog, is a DNA glycosylase that removes adenine residues that are
incorrectly added opposite of 8-oxo guanine, a chemical decay
product of oxidative damage [24]. MUTYH expression is found in the
hippocampal, cortical and cerebellar regions of the brain, and is
particularly robust in the cerebellum [25]. There is abundant MUTYH
expression in Purkinje neurons, with moderate expression in the
cytoplasm of granular cells [26].
Four isoforms of MUTYH exist in the brain [26]. Among these, only
one is expressed during embryonic development in the rat brain [27].
This isoform is present at a high level at E14, but gradually declines in
the embryo and neonate, while the other three isoforms appear and
gradually increase throughout post-natal development, reaching their
highest levels in the adult brain [27]. At the E14 stage, MUTYH is
present primarily in the nuclear fraction of Purkinje cells [27], while it
is present primarily in the mitochondrial fraction of adult Purkinje
cells [26,27]. The appearance of the three additional MUTYH isoforms
in the adult brain thus coincides with the end of proliferative neuron
growth and the maturation of mitochondrial function [27]. This
evidence suggests that MUTYH is involved in post-replicative DNA
repair in the nuclei of rapidly proliferating Purkinje cells, while in
post-mitotic Purkinje cells it is involved in the repair of oxidative
damage to the mitochondrial genomes.
An analysis of the sequence immediately surrounding the
ECA2:13074277 SNP revealed that this SNP lies immediately 3′
adjacent to a possible binding site for the transcription factor GATA-2.
GATA-2 is a transcription factor required for hematopoiesis and is
dynamically expressed in the central nervous system, giving rise to
hematopoietic progenitors, enveloping layer (EVL) cells and neurons
[28]. Each member of the GATA family is characterized by its ability to
bind to cis-acting DNA elements with the consensus core sequence
WGATAR. To data, six members of the GATA family have been
identiﬁed in vertebrates [29].
In the early phases of neurogenesis, a spot-like pattern of GATA-2
expression is observed in the ventral parts of the hindbrain [30].
Expression moves slowly into the hindbrain and ventral midbrain
regions, and GATA-2 expressing cells are found in a layer insertedbetween the ventricular zone and the layer of maturing neurons. Later
in development, the proliferative zone narrows markedly as neuro-
genic cell proliferation comes to an end. GATA-2 expressing cells
accumulate in the border of the proliferative zone, suggesting a direct
link between neuron formation and GATA-2 expression. This also
supports the view that GATA-2 is expressed by mid- and hind-brain
precursors in the immediate post-mitotic stage.
qPCR analyses in CA affected and unaffected horses, showed that
expression of MUTYH increased with the age of the horse. This is not
surprising, as it has been shown that MUTYH is one of a number of
genes that is upregulated in aged (24 months) versus young
(8 months) rats in the basal forebrain, which is selectively vulnerable
in human brain diseases [31]. However, we observed that the level of
upregulation was much greater in the control horses when compared
with the affected horses. While in the control horses there was a 75-
fold increase from the 2–3-month-old sample to the 4-year-old
sample, affected horses showed only a 37.16-fold increase overall
from the 5-month-old sample to the 6-year-old sample. This suggests
that MUTYH expression is negatively altered in horses affected with
CA. Given the proximity of the candidate SNP to the possible GATA-2
binding site, we hypothesize that it may impair the enhancer, thus
leading to a lower than required level of expression ofMUTYH. Lower
levels of MUTYH could result in reduced protection of either nuclear
or mitochondrial DNA from oxidative damage in Purkinje cells and
apoptosis. The level of MUTYH reduction could be variable enough to
account for variation in age of onset of the disease and the level of
debilitation. Additional control and affected samples of various ages
will be needed in order to fully investigate this hypothesis. Further
studies should also include evaluating the binding capacity of the
sequence encompassing ECA2:13074277 for the GATA-2 protein in
affected and unaffected horses.
The identiﬁcation of a conserved haplotype, including the putative
CA mutation, has allowed testing of suspected affected foals and
potential breeding animals for the presence of the disease. The
haplotype has been used to identify carrier animals and to diagnose
several foals for which CA was later conﬁrmed by histopathology
post-euthanasia. To date, approximately 4200 horses have been
tested for the presence of CA. A carrier rate of 19.7% has been
observed, although because of the preferential selection by owners for
testing animals from particular lineages, this may overestimate the
carrier rate for the entire population. Three of the 41 horses from the
general Arabian population tested were heterozygous for the
extended haplotype spanning the 142 kb region, and given the carrier
rate among Arabians, it is very possible that these three animals are
carriers of CA. Among tested animals, 1.4% were determined to be
affected by CA (two copies of the CA haplotype and the putative CA
mutation). Most of these animals display the characteristic signs of
CA. However, to date nine horses have been identiﬁed as genotyp-
ically affected with CA that do not show outward signs of the disease
based on owners' observation.
The occurrence of homozygosity of the CA haplotype and the
putative CA mutation in phenotypically unaffected horses raises the
question of variable expression of the disease. Age of onset and
severity of signs is variable among horses affected with CA; some
present signs of the disease almost immediately after birth, while
others are several months of age when signs are ﬁrst observed.
Additionally, some affected horses show severe expression of the
disease, with almost constant head tremors and a high degree of
ataxia, making them extremely difﬁcult to handle. Other affected
horses are very high functioning, with only occasional missteps in gait
and a very mild head tremor during intentional movement. In some
instances, “mildly affected” horses will show increasing severity of
their signs into adulthood, but this is not always the case. The range of
expression therefore raises the possibility that, in some cases, horses
could have the affected genotype and show no outward signs. If
lowered MUTYH expression is the cause of CA in horses, the variable
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oxidative damage to nuclear or mitochondrial DNA suffered by
individual horses. It is also possible that a small subset of the Arabian
population carries a suppressor mutation that can compensate for the
effects of the disease.
The cost of an affected foal to an Arabian breeder in terms of lost
revenue can be signiﬁcant, as many of these foals come from valuable
breeding stock. As well, the birth of a CA foal causes emotional distress
to the owners. Affected foals are often euthanized, as they are never
able to perform in hand or be ridden safely. Development of a genetic
test to screen for the speciﬁc CA mutation will allow diagnosis of CA
carriers prior to breeding and it will provide data to estimate the
carrier frequency in the Arabian breed. Pedigree analyses of the horses
in the CA families indicate that the mutation was present in related
horses that were breeding in the 1930s and that are common
ancestors in many Arabian bloodlines. Therefore, the frequency of
carriers in the breed may not be negligible. Genetic screening of
breeding stock will allow breeders to avoid mating two carriers
together, thus eliminating the chances of producing an affected foal.
4. Materials and methods
4.1. Mapping resource
DNA samples were prepared from blood or hair root samples
collected from 32 horses in four paternal families that comprised 16
known carriers, 11 affected and ﬁve unaffected horses. Familial
structure of these four families is shown in Fig. S1. Based on pedigree
records, three of the four stallions shared common ancestors within
four generations; the fourth had a common ancestor nine generations
removed. The cerebellum from one affected foal in each family was
harvested post-mortem, ﬁxed in formalin and submitted to the
Anatomic Pathology Service, Veterinary Medicine Teaching Hospital,
University of California, Davis for conﬁrmation of CA diagnosis.
Genomic DNA was extracted from whole blood using a salt extraction
method [32]. Extraction of DNA from hair roots was performed
according to standard protocols at the Veterinary Genetics Laboratory
(VGL) [33].
4.2. PCR ampliﬁcation and fragment size analysis
Ampliﬁcation of microsatellites and SNP markers by PCR was
performed in 12.5 μL total volume reactions containing 2 μL of DNA
extract, 1× PCR buffer (Applied Biosystems, Foster City, CA, USA),
2.5 mM MgCl2, 200 μM of each dNTP, 0.5 U Taq DNA Polymerase, and
3.5 μL of primer mix at optimized concentrations. Annealing tem-
peratures were also optimized for each pair of primers, and varied
from 56 °C to 60 °C. PCR cycling conditions were as follows: A hot start
of 90 °C for 5 min was performed, followed by four cycles of 94 °C for
1 min, optimized annealing temperature for 30 s and 72 °C for 30 s, 25
cycles of 94 °C for 45 s, optimized annealing temperature for 30 s and
72 °C for 30 s, and a ﬁnal extension of 72 °C for 30 min. PCR products
were labeled using ﬂuorescent M13 tails and separated by capillary
electrophoresis on ABI 3730 DNA Sequencers (Applied Biosystems,
Foster City, CA, USA). STRand software (http://www.vgl.ucdavis.edu/
informatics/strand.php) was used to determine allele fragment
lengths.
4.3. Linkage analysis
A whole genome scan was conducted on the four paternal families
segregating for CA using 335 microsatellites that spanned all 31 horse
autosomes. These microsatellites were obtained from published
reports. Co-segregation analyseswere performedwith the TWOPOINT
option of CRI-MAP [34] between each informative marker and CA
status to identify linkedmarkers. Genotype data for ECA2markers andCA were also analyzed with linkage software SIBPAL from the S.A.G.E.
package. (SAGE, Department of Epidemiology and Biostatistics, Case
Western Reserve University, Cleveland, OH, USA) SIBPAL calculates
the excess allele sharing by comparison with the null hypothesis
under no linkage by t statistics.
4.4. Marker development
BLAST comparisons of TKY615 with ECA2 genomic sequence
(http://genome.ucsc.edu, version 2) were used to identify an
additional 25 microsatellites spanning approximately 6 Mb around
TKY615. Twelve SNPs were identiﬁed by direct sequencing of nine
potential candidate genes using horse-speciﬁc primers developed
from genomic sequence. One additional SNP in the region of interest
was identiﬁed from SNPs available on the Illumina Equine SNP50 Bead
Chip. Allele-speciﬁc primers that differed in size by 2–3 base pairs as
well as ﬂuorescence color were designed using Netprimer (http://
www.premierbiosoft.com/netprimer/) to genotype the mapping
families for identiﬁed SNP markers. Direct sequencing was performed
using the Big Dye® Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems, Foster City, CA, USA) according to manufacturer's
instructions. Total reaction volume for cycle sequencing was 10 μL,
including 2 μL of PCR product and 0.5 μL each of 20 μM forward or
reverse primers.
4.5. Haplotype analysis
Association of marker alleles with the CA phenotype was
performed on 83 Arabian horses segregating for CA as well as a
control group of 41 Arabian horses drawn from the general
population. The 83 horses segregating for CA consisted of 23 affected
horses, 45 carriers, and 15 unaffected horses. Haplotypes and allele
frequencies were obtained from genotypes collected for all horses at
each of the 39 loci. Allele frequencies were calculated by direct count
and haplotyping was done by hand. Chi-squares and associated p
values for the probability of allele frequencies in the CA population
were calculated using a 2×2 contingency table and one degree of
freedom. A p value was assigned based on the null hypothesis that the
alleles of each marker were randomly distributed throughout both
populations.
4.6. Primer development and PCR of genes in the CA region
At least one affected and one unaffected horse were sequenced for
the 49.7 kb region identiﬁed as containing the CA mutation. Horse-
speciﬁc primers designed to cover the exons and introns of genes
within the genomic region of interest were developed from the
equine reference genome (available at http://www.genome.ucsc.edu/).
Ampliﬁcation of genomic regions by PCR was performed in 25 μL total
volume reactions containing 2–4 μL of DNA extract, 1× PCR buffer
(Applied Biosystems, Foster City, CA, USA), 2.5 mM MgCl2, 200 μM of
each dNTP, 0.5 U Taq DNA Polymerase, and 7.0 μL of primer mix at
optimized concentrations. Annealing temperatures were optimized for
all primer pairs. The cycling program used for PCR was identical to that
described in subsection 4.2. PCR products were electrophoresed on 1.5%
agarose gels to identify correct band sizes, and optimized PCR products
were puriﬁed for sequencing using either Sephadex gel ﬁltration (Edge
Biosystems, Gaithersburg, MD, USA) or gel extraction with resin
ﬁltration (Invitrogen, Carlsbad, CA, USA).
4.7. Sequencing of PCR products
Sequencing was performed using the Big Dye® Terminator v3.1
Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA). Total
reaction volumewas 10 μL, including 2 μL of PCR product and 0.5 μL of
20 μM forward or reverse primers. Separation of sequencing products
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Sequencers (Applied Biosystems, Foster City, CA, USA). Analysis of
sequences was performed using Lasergene 6 SeqMan software
(DNASTAR, Madison, WI, USA). The sequence of affected horses was
compared with that of the sequenced unaffected horses and the
equine reference genome (available athttp://www.genome.ucsc.edu/).
Mutations that displayed homozygosity in the affected horses but
were absent in unaffected horses were selected for further study.
4.8. Genotyping of SNPs
A total of 22 mutations were identiﬁed across all genes in the CA
region. Allele-speciﬁc primers that differed in size by 2–3 base pairs as
well as ﬂuorescence color were designed to genotype the mapping
families for each SNP. SNPs were genotyped on the CA families to
validate segregation with the trait and on 140 horses representing
10 breeds: Standardbreds, Andalusians, Thoroughbreds, Miniature
Horses,Morgans,Hackneys,Hanoverians,Norwegian Fjords, Percherons,
Quarter Horses, and DutchWarmbloods.
4.9. Isolation of total RNA and generation of complete cDNA
Three unaffected and three affected animals were used for
quantiﬁcation of gene expression. The control (unaffected) horses
included a 2–3-month-old Paso Fino foal, a 23.5-month-old Thor-
oughbred horse, and a 4-year-old Thoroughbred horse. The absence of
CA was conﬁrmed histopathologically by the Pathology service at the
UC Davis School of Veterinary Medicine. The affected horses included
a 5-month-old Arabian foal, a 9-month-old Arabian foal, and a 6-year-
old Arabian gelding. Conﬁrmatory CA diagnosis for the three affected
horses was done by histopathological examination, the ﬁrst at the
School of Veterinary Medicine, University of Pennsylvania and the
latter two at the UC Davis School of Veterinary Medicine. Cerebellar
tissues were collected immediately post-mortem. Brieﬂy, the cere-
bellum of each horse was removed and cut sagittally through the
vermis. Tissue samples were then taken from the midline of the
cerebellum at the junction of the molecular and granular layers to
ensure recovery of Purkinje cells. Total RNA was isolated from the
cerebellar samples of each animal using Trizol Reagent (Invitrogen,
Carlsbad, CA, USA) per manufacturer's instructions. RNA was
quantiﬁed by spectrophotometry on a NanoDrop 2000 spectropho-
tometer (Thermo Scientiﬁc, Wilmington, DE, USA) and quality was
determined by loading 1 μg of RNA on a 1% MOPS/formaldehyde
agarose gel. Samples were ﬁrst DNase-treated to remove any residual
DNA by heating for 10 min at 65 °C. For complete cDNA synthesis, 1 μg
of RNA was combined with 1 μL of an OligoDT(18) primer, 1 μL 10 mM
dNTPs, DNaseI, and DEPC dH2O to 13 μL. Samples were heated for
5 min at 65 °C. Following this step, a mastermix of 4 μL 5× RT Buffer
(Invitrogen, Carlsbad, CA, USA), 1 μL 0.1 M DTT, 1 μL RNasin, and 1 μL
SuperScriptII reverse transcriptase (Invitrogen, Carlsbad, CA, USA)
was then added. cDNA synthesis was achieved by heating at 25 °C for
5 min, followed by 40 °C for 1 h and then heating to 70 °C for 15 min
to destroy any remaining enzyme. All resulting cDNA samples were
stored at −70 °C until used. Total RNA was successfully retrieved
from 2 samples of the 2–3 month-old control horse, 1 sample of the
23.5-month-old control horse, 2 samples of the 4-year-old control
horse, 1 sample of the 5-month-old affected horse, 3 samples of the 9-
month-old affected horse, and 2 samples of the 6-year-old affected
horse, for a total of 8 RNA samples.
4.10. qPCR
All qPCR reactions were run in 96-well Microamp Fast Optical well
plates (Applied Biosystems, Foster City, CA, USA) on an ABI 7500 fast
thermocycler (Applied Biosystems, Foster City, CA, USA). Synaptophy-
sin (SYP) was used as a reference gene, because of its stability ofexpression in brain tissue and its speciﬁcity of expression in neurons
[35]. All 9 samples were run in triplicate on both MUTYH and SYP
except for the 5-month-old affected horse, for which four reactions
were performed, and the 23.5-month-old control horse, for which six
reactions were performed. Because only one cDNA sample was
retrieved from each of these horses, additional reactions were
performed to increase the number of data points. Each reaction
contained 10 μl of Fast SYBR Green PCR mastermix, SYP- or MUTYH-
speciﬁc forward and reverse primers at optimized concentrations,
50 ng of cDNA and dH2O to a total sample volume of 20 μl. Standard
curves for each gene were constructed using cDNA template
consisting of pooled cDNA from different samples at concentrations
of 100, 50, 25, 12.5, 6.25, 3.125, and 0.0 ng/reaction. Both genes
were ampliﬁed on the same plate with primers MUTYH-forward:
5′-TACGACAGAGAGAAGCGGGA-3′ and MUTYH-reverse: 5′-AGAACA-
CAGGTGGCAGAGCA-3′, SYP-forward: 5′-GGCACTACCAAAGTCTTCCTG-
3′ and SYP-reverse: 5′-CCGATGAACTAACAAGCCACA-3′.
Each 96-well plate was run using a 3-stage thermocycling
program. Stage 1 consisted of a 1 min hot start at 95 °C. Ampliﬁcation
was carried out in stage 2 and consisted of 3 steps: denaturation for
15 s at 94 °C, annealing for 30 s at 60 °C, and product extension for
30 s at 72 °C. Fluorescence data was collected on the annealing step.
Stage 2 was repeated for a total of 40 cycles. In stage 3, dissociation
was measured in 3 steps: 95 °C for 15 s, 60 °C for 1 min, and 95 °C for
ﬁfteen seconds to create a melt curve. Data from the qPCR reactions
were analyzed using ABI 7500 Software v2.0.1 (Applied Biosystems,
Foster City, CA). The identiﬁed quantities of gene expression,
measured in ng, were averaged among all samples for each horse.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ygeno.2010.11.006.
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